Official blog
Compliance-aware guides and brand updates for adult consumers.
Page 27 of 36 / 848 articles
Over 200 articles, the nicotine landscape has been mapped from every angle. This final reflection is not a conclusion—the story continues—but an attempt to name what the series has been about, at its deepest level.
Rural Americans smoke at higher rates than urban Americans—and have dramatically less access to cessation services. The geography of smoking cessation is a map of health inequity.
The first generation of nicotine vaccines failed in Phase III trials. The next generation—using monoclonal antibodies, nanoparticle carriers, and genetic immunization—is showing renewed promise.
What's changed, what hasn't, and what's next in nicotine policy. A forward-looking assessment written from the vantage point of 2026, projecting toward the end of the decade.
Flavors aren't just about enjoyment. They're about breaking the psychological association between nicotine and tobacco, creating a clean sensory break that helps former smokers stay quit. The psychology of flavor is underappreciated.
From Hon Lik's first e-cigarette to the WHO's warning on nicotine pouches, the nicotine landscape has been transformed in two decades. A chronological tour of the events that shaped the modern nicotine world.
People with PTSD smoke at two to three times the general population rate. For many, nicotine is a form of self-medication for hyperarousal, emotional numbing, and the cognitive symptoms of trauma. Understanding this connection is essential.
Hookah smoking has exploded globally—particularly among youth and young adults who believe it's safer than cigarettes. It's not. The waterpipe epidemic is the most underappreciated dimension of the global tobacco crisis.
The tools exist to eliminate combustible tobacco within a generation. The evidence supports it. The economics favor it. What's missing is the choice to make it happen. The final article in this series argues for choosing now.
NRT hasn't changed much in 40 years—patches, gum, lozenges. But a quiet revolution in nicotine delivery technology is underway, from smart patches to inhaled nicotine to genetically-guided dosing. What's in the pipeline?
If you had to summarize the entire nicotine policy debate in a single sentence, what would it be? Ten experts give their answers—and the range of responses is instructive.
Behind every e-liquid flavor is a flavorist—a professional trained in the chemistry and sensory science of taste. The craft of e-liquid flavor development is sophisticated, largely invisible, and central to the vaping experience.
Governments worldwide collect over $250 billion annually in tobacco taxes. That revenue funds healthcare, education, and children's programs. The fiscal dependency on smoking is the single greatest barrier to ending it.
Smoking accelerates biological aging—not just in the lungs and skin, but at the cellular level. Telomere shortening, epigenetic clocks, and mitochondrial dysfunction all point to nicotine's role in the aging process.
The first 100 articles mapped the nicotine landscape. Another 100 articles later, what's changed? The evidence has advanced. The policy battles have intensified. And the fundamental tensions remain unresolved.
The tobacco control establishment was forged in the battles against Big Tobacco in the 1990s. A new generation of researchers, shaped by harm reduction and digital culture, is challenging the old orthodoxies.
PMI and BAT publish glossy sustainability reports with net-zero targets. But their core business—selling combustible cigarettes—is fundamentally carbon-intensive. Can an industry built on combustion ever be 'sustainable'?
Ten former smokers describe their transition from cigarettes to nicotine pouches. Their stories illustrate the diversity of pathways away from combustible tobacco—and the common themes that unite them.
Which countries are leading on evidence-based nicotine policy—and which are falling behind? A comparative assessment of regulatory frameworks across 30 countries, measuring how well policies align with the evidence.
What will the nicotine retail environment look like in 2035? The independent vape shop is an endangered species. What replaces it—and what's gained or lost in the transition?
We've focused on secondhand smoke and secondhand vapor. But what about the nicotine that settles on surfaces and circulates in indoor air? The thirdhand nicotine question is the next frontier in exposure science.
What would a just nicotine policy look like from the user's perspective? A thought experiment in centering the people most affected by the policies we debate.
6-methylnicotine, nicotyrine, and other nicotine analogues are appearing in vaping products—and no regulatory framework is prepared for them. The next nicotine crisis isn't on the horizon. It's on the shelves.
Every nicotine debate features the same arguments, deployed by the same camps, with the same supporting evidence. Here's a guide to recognizing them—and to evaluating which ones hold up under scrutiny.
Products
Select a product to view details, highlights, and technical specifications.
